14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection

NCT06687499 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori
Drug Resistance, Multiple

Interventions

DRUG: Bismuth-based susceptibility-guided treatment

Sponsor

National Cheng-Kung University Hospital

Collaborators

[object Object]